A new study in ECNU Review of Education argues that micro-credentials (short, competency-based qualifications requiring verified classroom evidence) offer a fundamentally different approach to teacher professional development. Rather than rewarding "seat time," micro-credentials restore educator agency and link learning to verifiable classroom results. With teacher job satisfaction having nearly cratered over the past fifteen years and a global retention crisis deepening, the author contends that micro-credentials represent a timely and necessary reimagining of how educators can take control of their learning.

SEATTLE, Wash. – March 26, 2026 – Global maternal deaths have declined over the past three decades, yet progress has slowed in recent years and remains uneven across countries, according to new Global Burden of Disease (GBD) 2023 research published today in The Lancet Obstetrics, Gynaecology, & Women’s Health. 

Households with high incomes are the main beneficiaries of subsidy programmes supporting the clean energy transition. A team of researchers from the University of Freiburg, Stanford University, Indiana University and the University of Pennsylvania has analysed why this is the case and how energy policy can be made more equitable. The results have now been published in the journal Nature Reviews Clean Technology.

Fortifying staple foods with essential vitamins and minerals is a cheap and effective way to ensure that people have access to nutrients that may be lacking in their normal diets. These efforts have countered debilitating deficiencies that lead to conditions like rickets and pellagra, and have increased health and wellbeing around the globe.

About The Study: Global early-stage drug development has nearly doubled over the past decade, shifting from a system dominated by the U.S. toward a 2-hub structure centered on the U.S. and China. Because early-stage drug candidates shape future drug approvals and investment, these shifts may have downstream implications for regulatory coordination, scientific workforce development, and patient access to new therapies. Continued monitoring will be essential for policymakers to understand these consequences and to design appropriate financial and regulatory incentives.

Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to new research described by Georgetown University health policy experts.